Briefs: Lyfius Pharma and Aurobindo Pharma
Lyfius Pharma restarts operations at Penicillin-G manufacturing facility
Lyfius Pharma restarts operations at Penicillin-G manufacturing facility
The pet dog population alone is expected to increase from 21.4 million in 2019 to 51.5 million by 2028
Acquisition to be followed by merger; strengthens Torrent’s IPM market presence
The company has been awarded a contract for the supply of essential pharmaceutical formulations to government health institutions across Rajasthan
The inspection concluded with zero Form 483 observations
J B Chemicals and Pharmaceuticals receives ANDA approval for Amitriptyline Hydrochloride Tablets from USFDA
TEVIMBRA is a uniquely designed anti-PD-1 monoclonal antibody developed by BeiGene (now BeOne Medicines)
The company received seven observations in the Form-483
Sun Pharma gets 8 observations from USFDA for Halol facility
Subscribe To Our Newsletter & Stay Updated